Imaging of the neuromelanin (NM) has recently developed as a relevant biomarker of Parkinson’s disease (PD). Here, we present a longitudinal, quantitative, multiparametric study on the AAV-hTyr rat model of PD with NM accumulation in the right substantia nigra. Our protocol allowed to obtain NM-sensitive image, as well as R1, R2* and qMT in a single session. Longitudinal acquisition on AAV-hTyr rats showed inverted U-shaped curve of NM-MRI contrast-to-noise ratio, suggesting NM accumulation followed by neurodegeneration. R1, R2*, MPF and motor symptoms support this hypothesis. Our work may help to understand the pathogenesis of this PD model and identify biomarkers.
No takes yet. Share an insight, caveat, or question.
Pérot et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: